Mitochondrial permeability transition in the CNS - Composition, regulation, and pathophysiological relevance

Handbook of Neurochemistry and Molecular Neurobiology: Brain Energetics. Integration of Molecular and Cellular Processes

Volumn , Issue , 2007, Pages 667-702

  Wieloch, T ^a   Mattiasson, G ^a   Hansson, M J ^a   Elmer E ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900975500     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-30411-3_25     Document Type: Chapter

References (344)

1. Abe T, Takagi N, Nakano M, Takeo S. 2004. The effects of monobromobimane on neuronal cell death in the hippocampus after transient global cerebral ischemia in rats. Neurosci Lett 357:227-231.
2. Adams V, Bosch W, Schlegel J, Wallimann T, Brdiczka D. 1989. Further characterization of contact sites from mitochondria of different tissues: Topology of peripheral kinases. Biochim Biophys Acta 981:213-225.
3. Adembri C, Venturi L, Tani A, Chiarugi A, Gramigni E, et al. 2006. Neuroprotective effects of propofol in models of cerebral ischemia: Inhibition of mitochondrial swelling as a possible mechanism. Anesthesiology 104:80-89.
4. 2+-induced permeabilization of rat liver mitochondria. Biochem J 239:19-29.
5. Alano CC, Beutner G, Dirksen RT, Gross RA, Sheu SS. 2002. Mitochondrial permeability transition and calcium dynamics in striatal neurons upon intense NMDA receptor activation. J Neurochem 80:531-538.
6. Alessandri B, Rice AC, Levasseur J, DeFord M, Hamm RJ, et al. 2002. Cyclosporin A improves brain tissue oxygen consumption and learning/memory performance after lateral fluid percussion injury in rats. J Neurotrauma 19:829-841.
7. Amerkhanov ZG, Yegorova MV, Markova OV, Mokhova EN. 1996. Carboxyatractylate- and cyclosporin A-sensitive uncoupling in liver mitochondria of ground squirrels during hibernation and arousal. Biochem Mol Biol Int 38:863-870.
8. Anderson MF, Sims NR. 2002. The effects of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions. J Neurochem 81:541-549.
9. Andrabi SA, Sayeed I, Siemen D, Wolf G, Horn TF. 2004. Direct inhibition of the mitochondrial permeability transition pore: A possible mechanism responsible for antiapoptotic effects of melatonin. FASEB J 18:869-871.
10. Andreyev AY, Fahy B, Fiskum G. 1998. Cytochrome c release from brain mitochondria is independent of the mitochondrial permeability transition. FEBS Lett 439:373-376.
11. Anholt RR, Pedersen PL, De Souza EB, Snyder SH. 1986. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem 261:576-583.
12. Armstrong JS. 2006. Mitochondrial membrane permeabilization: The sine qua non for cell death. Bioessays 28:253-260.
13. Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, et al. 2002. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 52:54-61.
14. Auer RN, Wieloch T, Olsson Y, Siesjo BK. 1984. The distribution of hypoglycemic brain damage. Acta Neuropathol (Berl) 64:177-191.
15. Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V. 2004. In self-defence: Hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem J 377:347-355.
16. Azzi A, Azzone GF. 1965. Swelling and shrinkage phenomena in liver mitochondria. I. Large amplitude swelling induced by inorganic phosphate and by ATP. Biochim Biophys Acta 105:253-264.
17. Bai G, Rama Rao KV, Murthy CR, Panickar KS, Jayakumar AR, et al. 2001. Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes. J Neurosci Res 66:981-991.
18. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, et al. 2005. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434:658-662.
19. Bambrick L, Kristian T, Fiskum G. 2004. Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection. Neurochem Res 29:601-608.
20. Bambrick LL, Chandrasekaran K, Mehrabian Z, Wright C, Krueger BK, et al. 2006. Cyclosporin A increases mitochondrial calcium uptake capacity in cortical astrocytes but not cerebellar granule neurons. J Bioenerg Biomembr 38:43-47.
21. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, et al. 2005. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem 280:18558-18561.
22. Bauer MK, Schubert A, Rocks O, Grimm S. 1999. Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J Cell Biol 147:1493-1502.
23. Beal MF. 1998. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366:211-223.
24. 2+ release induced by t-butyl hydroperoxide or oxalacetate. The effect of ruthenium red. J Biol Chem 257:7161-7171.
25. Berman SB, Watkins SC, Hastings TG. 2000. Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: Evidence for reduced sensitivity of brain mitochondria. Exp Neurol 164:415-425.
26. Bernardi P. 1992. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem 267:8834-8839.
27. Bernardi P. 1999. Mitochondrial transport of cations: Channels, exchangers, and permeability transition. Physiol Rev 79:1127-1155.
28. Bernardi P, Petronilli V. 1996. The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal. J Bioenerg Biomembr 28:131-138.
29. Bernardi P, Broekemeier KM, Pfeiffer DR. 1994. Recent progress onregulationof the mitochondrial permeability transition pore, a cyclosporin-sensitive pore in the inner mitochondrial membrane. J Bioenerg Biomembr 26:509-517.
30. Bernardi P, Krauskopf A, Basso E, Petronilli V, Blalchy-Dyson E, et al. 2006. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 273:2077-2099.
31. Bernardi P, Petronilli V, Di Lisa F, Forte M. 2001. A mitochondrial perspective on cell death. Trends Biochem Sci 26:112-117.
32. Bernardi P, Vassanelli S, Veronese P, Colonna R, Szabo I, et al. 1992. Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J Biol Chem 267:2934-2939.
33. Berson A, Descatoire V, Sutton A, Fau D, Maulny B, et al. 2001. Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepatocytes: Role of mitochondrial permeability transition and metabolic activation. J Pharmacol Exp Ther 299:793-800.
34. Beutner G, Ruck A, Riede B, Brdiczka D. 1998. Complexes between porin, hexokinase, mitochondrial creatine kinase, and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta 1368:7-18.
35. Beutner G, Ruck A, Riede B, Welte W, Brdiczka D. 1996. Complexes between kinases, mitochondrial porin, and adenylate translocator in rat brain resemble the permeability transition pore. FEBS Lett 396:189-195.
36. Blachly-Dyson E, Forte M. 2001. VDAC channels. IUBMB Life 52:113-118.
37. Blomgren K, Hagberg H. 2006. Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic Biol Med 40:388-397.
38. Bono F, Lamarche I, Prabonnaud V, Le Fur G, Herbert JM. 1999. Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Biochem Biophys Res Commun 265:457-461.
39. Brdiczka DG, Zorov DB, Sheu SS. 2006. Mitochondrial contact sites: Their role in energy metabolism and apoptosis. Biochim Biophys Acta 1762:148-163.
40. Brenner C, Cadiou H, Vieira HL, Zamzami N, Marzo I, et al. 2000. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19:329-336.
41. Broekemeier KM, Pfeiffer DR. 1989. Cyclosporin A-sensitive and insensitive mechanisms produce the permeability transition in mitochondria. Biochem Biophys Res Commun 163:561-566.
42. Broekemeier KM, Pfeiffer DR. 1995. Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: Relationship between pore opening and the activity of mitochondrial phospholipases. Biochemistry 34:16440-16449.
43. 2+ and oxidative stress. FEBS Lett 304:192-194.
44. Broekemeier KM, Dempsey ME, Pfeiffer DR. 1989. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 264:7826-7830.
45. 2+ overload than nonsynaptic mitochondria. J Biol Chem 281:11658-11668.
46. Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, et al. 1997. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia. Ann Neurol 41:646-653.
47. Brustovetsky N, Dubinsky JM. 2000. Dual responses of CNS mitochondria to elevated calcium. J Neurosci 20:103-113.
48. 2+. Biochemistry 35:8483-8488.
49. Brustovetsky N, Brustovetsky T, Dubinsky JM. 2001. On the mechanisms of neuroprotection by creatine and phosphocreatine. J Neurochem 76:425-434.
50. Brustovetsky N, Brustovetsky T, Jemmerson R, Dubinsky JM. 2002a. Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. J Neurochem 80:207-218.
51. 2+-dependent channel formed by recombinant ADP/ATP carrier from Neurospora crassa resembles the mitochondrial permeability transition pore. Biochemistry 41:11804-11811.
52. Brustovetsky N, Brustovetsky T, Purl KJ, Capano M, Crompton M, et al. 2003a. Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J Neurosci 23:4858-4867
53. Brustovetsky N, Dubinsky JM, Antonsson B, Jemmerson R. 2003b. Two pathways for tBID-induced cytochrome c release from rat brain mitochondria: BAK versus BAX-dependence. J Neurochem 84:196-207.
54. Brustovetsky N, LaFrance R, Purl KJ, Brustovetsky T, Keene CD, et al. 2005a. Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's disease. J Neurochem 93:1361-1370.
55. Brustovetsky T, Antonsson B, Jemmerson R, Dubinsky JM, Brustovetsky N. 2005b. Activation of calcium-independent phospholipase A (iPLA) in brain mitochondria and release of apoptogenic factors by BAX and truncated BID. J Neurochem 94:980-994.
56. Brustovetsky NN, Egorova MV, Gnutov D, Mokhova EN, Skulachev VP. 1993. Cyclosporin A suppression of uncoupling in liver mitochondria of ground squirrel during arousal from hibernation. FEBS Lett 315:233-236.
57. Bryson JM, Coy PE, Gottlob K, Hay N, Robey RB. 2002. Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J Biol Chem 277:11392-11400.
58. Buki A, Okonkwo DO, Povlishock JT. 1999. Postinjury cyclosporin Aadministration limits axonal damage and disconnection in traumatic brain injury. J Neurotrauma 16:511-521.
59. Butcher SP, Henshall DC, Teramura Y, Iwasaki K, Sharkey J. 1997. Neuroprotective actions of FK506 in experimental stroke: In vivo evidence against an antiexcitotoxic mechanism. J Neurosci 17:6939-6946.
60. Cao G, Clark RS, Pei W, Yin W, Zhang F, et al. 2003. Translocation of apoptosis-inducing factor in vulnerable neurons after transient cerebral ischemia and in neuronal cultures after oxygen-glucose deprivation. J Cereb Blood Flow Metab 23:1137-1150.
61. Cassarino DS, Swerdlow RH, Parks JK, Parker WD Jr., Bennett JP Jr. 1998. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochem Biophys Res Commun 248:168-173.
62. Cesura AM, Pinard E, Schubenel R, Goetschy V, Friedlein A, et al. 2003. The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore. J Biol Chem 278:49812-49818.
63. Chalmers S, Nicholls DG. 2003. The relationship between free and total calcium concentrations in the matrix of liver and brain mitochondria. J Biol Chem 278:19062-19070.
64. Chelli B, Falleni A, Salvetti F, Gremigni V, Lucacchini A, et al. 2001. Peripheral-type benzodiazepine receptor ligands: Mitochondrial permeability transition induction in rat cardiac tissue. Biochem Pharmacol 61:695-705.
65. Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, et al. 2000. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797-801.
66. Cheng EH, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ. 2003. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301:513-517.
67. Chernyak BV, Bernardi P. 1996. The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites. Eur J Biochem 238:623-630.
68. Chinopoulos C, Starkov AA, Fiskum G. 2003. Cyclosporin A-insensitive permeability transition in brain mitochondria: Inhibition by 2-aminoethoxydiphenyl borate. J Biol Chem 278:27382-27389.
69. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
70. Clarke SJ, McStay GP, Halestrap AP. 2002. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin D at a different site from cyclosporin A. J Biol Chem 277:34793-34799.
71. Clarkson AN, Liu H, Pearson L, Kapoor M, Harrison JC, et al. 2004. Neuroprotective effects of spermine following hypoxic-ischemic-induced brain damage: A mechanistic study. FASEB J 18:1114-1116.
72. Cleren C, Starkov AA, Calingasan NY, Lorenzo BJ, Chen J, et al. 2005. Promethazine protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity. Neurobiol Dis 20:701-708.
73. Coert BA, Anderson RE, Meyer FB. 2000. Exogenous spermine reduces ischemic damage in a model of focal cerebral ischemia in the rat. Neurosci Lett 282:5-8.
74. Colbourne F, Sutherland GR, Auer RN. 1999. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia. J Neurosci 19:4200-4210.
75. Colell A, Garcia-Ruiz C, Lluis JM, Coll O, Mari M, et al. 2003. Cholesterol impairs the adenine nucleotide translocatormediated mitochondrial permeability transition through altered membrane fluidity. J Biol Chem 278:33928-33935.
76. Connern CP, Halestrap AP. 1992. Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin. Biochem J 284(Pt 2), 381-385.
77. Cornet S, Spinnewyn B, Delaflotte S, Charnet C, Roubert V, et al. 2004. Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline. Eur J Pharmacol 505:111-119.
78. Costantini P, Chernyak BV, Petronilli V, Bernardi P. 1995. Selective inhibition of the mitochondrial permeability transition pore at the oxidation-reduction sensitive dithiol by monobromobimane. FEBS Lett 362:239-242.
79. Costantini P, Chernyak BV, Petronilli V, Bernardi P. 1996. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J Biol Chem 271:6746-6751.
80. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, et al. 2002. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 158:507-517.
81. Crompton M. 1999. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341(Pt 2):233-249.
82. Crompton M. 2000. Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol 529 Pt (1): 11-21.
83. Crompton M. 2003. On the involvement of mitochondrial intermembrane junctional complexes in apoptosis. Curr Med Chem 10:1473-1484.
84. 2+ overload. Eur J Biochem 178:489-501.
85. Crompton M, Heid I. 1978. The cycling of calcium, sodium, and protons across the inner membrane of cardiac mitochondria. Eur J Biochem 91:599-608.
86. Crompton M, Barksby E, Johnson N, Capano M. 2002. Mitochondrial intermembrane junctional complexes and their involvement in cell death. Biochimie 84:143-152.
87. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 255:357-360.
88. Crompton M, Kunzi M, Carafoli E. 1977. The calciuminduced and sodium-induced effluxes of calcium from heart mitochondria. Evidence for a sodium-calcium carrier. Eur J Biochem 79:549-558.
89. Crompton M, Virji S, Doyle V, Johnson N, Ward JM. 1999. The mitochondrial permeability transition pore. Biochem Soc Symp 66:167-179.
90. Crompton M, Virji S, Ward JM. 1998. Cyclophilin-D binds stronglytocomplexesofthe voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur J Biochem 258:729-735.
91. Czerniczyniec A, Bustamante J, Lores-Arnaiz S. 2006. Modulation of brain mitochondrial function by deprenyl. Neurochem Int 48:235-241.
92. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, et al. 1993. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 90:9808-9812.
93. Deshpande J, Bergstedt K, Linden T, Kalimo H, Wieloch T. 1992. Ultrastructural changes in the hippocampal CA1 region following transient cerebral ischemia: Evidence against programmed cell death. Exp Brain Res 88:91-105.
94. Di Paola M, Zaccagnino P, Oliveros-Celis C, Lorusso M. 2006. Arachidonic acid induces specific membrane permeability increase in heart mitochondria. FEBS Lett 580:775-781.
95. Dirnagl U, Iadecola C, Moskowitz MA. 1999. Pathobiology of ischemic stroke: An integrated view. Trends Neurosci 22:391-397.
96. Dolder M, Walzel B, Speer O, Schlattner U, Wallimann T. 2003. Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J Biol Chem 278:17760-17766.
97. Dolder M, Wendt S, Wallimann T. 2001. Mitochondrial creatine kinase in contact sites: Interaction with porin and adenine nucleotide translocase, role in permeability transition, and sensitivity to oxidative damage. Biol Signal Recept 10:93-111.
98. Dubinsky JM. 2005. CNS mitochondria in neurodegenerative disorders. Antioxid Redox Signal 7:1089-1091.
99. Dubinsky JM, Levi Y. 1998. Calcium-induced activation of the mitochondrial permeability transition in hippocampal neurons. J Neurosci Res 53:728-741.
100. Duchen MR, McGuinness O, Brown LA, Crompton M. 1993. On the involvement of a cyclosporin A-sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res 27:1790-1794.
101. Dugan LL, Kim-Han JS. 2004. Astrocyte mitochondria in in vitro models of ischemia. J Bioenerg Biomembr 36:317-321.
102. Empey PE, McNamara PJ, Young B, Rosbolt MB, Hatton J. 2006. Cyclosporin A disposition following acute traumatic brain injury. J Neurotrauma 23:109-116.
103. Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, et al. 1998. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb Blood Flow Metab 18:238-247.
104. Erecinska M, Silver IA. 1989. ATP and brain function. J Cereb Blood Flow Metab 9:2-19.
105. Estevez AY, Phillis JW. 1997. The phospholipase A2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion. Brain Res 752:203-208.
106. 2+ plus prooxidants. J Biol Chem 265:19955-19960.
107. Faustin B, Rossignol R, Rocher C, Benard G, Malgat M, et al. 2004. Mobilization of adenine nucleotide translocators as molecular bases of the biochemical threshold effect observed in mitochondrial diseases. J Biol Chem 279:20411-20421.
108. Fernandez-Gomez FJ, Galindo MF, Gomez-Lazaro M, Gonzalez-Garcia C, Cena V, et al. 2005. Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions. Neuroscience 133:959-967.
109. Ferrand-Drake M, Zhu C, Gido G, Hansen AJ, Karlsson JO, et al. 2003. Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis-inducing factor, cytochrome c, and caspase-3 activation in neurons exposed to transient hypoglycemia. J Neurochem 85:1431-1442.
110. Fink K, Zhu J, Namura S, Shimizu-Sasamata M, Endres M, et al. 1998. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J Cereb Blood Flow Metab 18:1071-1076.
111. Fontaine E, Eriksson O, Ichas F, Bernardi P. 1998a. Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation by electron flow through the respiratory chain complex I. J Biol Chem 273:12662-12668.
112. Fontaine E, Ichas F, Bernardi P. 1998b. A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J Biol Chem 273:25734-25740.
113. Fournier N, Ducet G, Crevat A. 1987. Action of cyclosporin on mitochondrial calcium fluxes. J Bioenerg Biomembr 19:297-303.
114. Friberg H, Connern C, Halestrap AP, Wieloch T. 1999. Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J Neurochem 72:2488-2497.
115. Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T. 1998. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci 18:5151-5159.
116. Fuks B, Talaga P, Huart C, Henichart JP, Bertrand K, et al. 2005. In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-3 (2H)-pyridazinone: A novel permeability transition pore inhibitor. Eur J Pharmacol 519:24-30.
117. Gadd ME, Broekemeier KM, Crouser ED, Kumar J, Graff G, et al. 2006. Mitochondrial iPLA2 activity modulates the release of cytochrome c from mitochondria and influences the permeability transition. J Biol Chem 281:6931-6939.
118. 2+-independent permeabilization of the inner mitochondrial membrane by peroxynitrite is mediated by membrane protein thiol cross-linking and lipid peroxidation. Arch Biochem Biophys 345:243-250.
119. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, et al. 2006. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 13:1423-1433.
120. Gillessen T, Grasshoff C, Szinicz L. 2002. Mitochondrial permeability transition can be directly monitored in living neurons. Biomed Pharmacother 56:186-193.
121. Gincel D, Shoshan-Barmatz V. 2004. Glutamate interacts with VDAC and modulates opening of the mitochondrial permeability transition pore. J Bioenerg Biomembr 36:179-186.
122. Gincel D, Zaid H, Shoshan-Barmatz V. 2001. Calcium binding and translocation by the voltage-dependent anion channel: A possible regulatory mechanism in mitochondrial function. Biochem J 358:147-155.
123. Gonzalez-Barroso MM, Fleury C, Levi-Meyrueis C, Zaragoza P, Bouillaud F, et al. 1997. Deletion of amino acids 261-269 in the brown fat uncoupling protein converts the carrier into a pore. Biochemistry 36:10930-10935.
124. Gonzalvez F, Pariselli F, Dupaigne P, Budihardjo I, Lutter M., et al. 2005. tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak. Cell Death Differ 12:614-626.
125. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, et al. 2001. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15:1406-1418.
126. Green DR, Kroemer G. 2004. The pathophysiology of mitochondrial cell death. Science 305:626-629.
127. Griffiths EJ, Halestrap AP. 1995. Mitochondrial nonspecific pores remain closed during cardiac ischemia, but open upon reperfusion. Biochem J 307(Pt 1):93-98.
128. 2+-stimulated generation of reactive oxygen species by the respiratory chain. Biochemistry 38:13279-13287.
129. Gunter TE, Pfeiffer DR. 1990. Mechanisms by which mitochondria transport calcium. Am J Physiol 258:C755-C786.
130. Halestrap A. 2005. Biochemistry: A pore way to die. Nature 434:578-579.
131. Halestrap AP. 1991. Calcium-dependent opening of a nonspecific pore in the mitochondrial inner membrane is inhibited at pH values below 7. Implications for the protective effect of low pH against chemical and hypoxic cell damage. Biochem J 278(Pt 3):715-719.
132. Halestrap AP. 1999. The mitochondrial permeability transition: Its molecular mechanism and role in reperfusion injury. Biochem Soc Symp 66:181-203.
133. Halestrap AP. 2004. Mitochondrial permeability: Dual role for the ADP/ATP translocator? Nature 430. Brief communication.
134. Halestrap AP. 2006. Calcium, mitochondria, and reperfusion injury: A pore way to die. Biochem Soc Trans 34:232-237.
135. Halestrap AP, Brennerb C. 2003. The adenine nucleotide translocase: A central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 10:1507-1525.
136. 2+-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 268:153-160.
137. Halestrap AP, Connern CP, Griffiths EJ, Kerr PM. 1997a. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischemia/reperfusion injury. Mol Cell Biochem 174:167-172.
138. Halestrap AP, Woodfield KY, Connern CP. 1997b. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 272:3346-3354.
139. Halestrap AP, Gillespie JP, O'Toole A, Doran E. 2000. Mitochondria and cell death: A pore way to die? Symp Soc Exp Biol 52:65-80.
140. Halestrap AP, Kerr PM, Javadov S, Woodfield KY. 1998. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1366:79-94.
141. Hansson MJ, Mansson R, Mattiasson G, Ohlsson J, Karlsson J, et al. 2004a. Brain-derived respiring mitochondria exhibit homogeneous, complete, and cyclosporin-sensitive permeability transition. J Neurochem 89:715-729.
142. Hansson MJ, Mattiasson G, Mansson R, Karlsson J, Keep MF, et al. 2004b. The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria. J Bioenerg Biomembr 36:407-413.
143. Hansson MJ, Persson T, Friberg H, Keep MF, Rees A, et al. 2003. Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res 960:99-111.
144. 2+ trigger site. Arch Biochem Biophys 195:460-467.
145. 2+-activated hydrophilic channel of the mitochondrial inner membrane by nucleotides. J Membr Biol 54:231-236.
146. He L, Lemasters JJ. 2002. Regulated and unregulated mitochondrial permeability transition pores: A new paradigm of pore structure and function? FEBS Lett 512:1-7.
147. Hoffmann B, Stockl A, Schlame M, Beyer K, Klingenberg M. 1994. The reconstituted ADP/ATP carrier activity has an absolute requirement for cardiolipin as shown in cysteine mutants. J Biol Chem 269:1940-1944.
148. Hoyt KR, Sharma TA, Reynolds IJ. 1997. Trifluoperazine- and dibucaine-induced inhibition of glutamate-induced mitochondrial depolarization in rat cultured forebrain neurons. Br J Pharmacol 122:803-808.
149. Hu BR, Liu CL, Ouyang Y, Blomgren K, Siesjo BK. 2000. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 20:1294-1300.
150. Huang HM, Ou HC, Xu H, Chen HL, Fowler C, et al. 2003. Inhibition of a-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death. J Neurosci Res 74:309-317.
151. Hunter DR, Haworth RA, Southard JH. 1976. Relationship between configuration, function, and permeability in calcium-treated mitochondria. J Biol Chem 251:5069-5077.
152. 2+ release. Arch Biochem Biophys 195:468-477.
153. 2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys 195:453-459.
154. Hunter FE Jr, Ford L. 1955. Inactivation of oxidative and phosphorylative systems in mitochondria by preincubation with phosphate and other ions. J Biol Chem 216:357-369.
155. Huser J, Blatter LA. 1999. Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. Biochem J 343 Pt (2): 311-317.
156. Ichas F, Mazat JP. 1998. From calcium signaling to cell death: Two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim Biophys Acta 1366:33-50.
157. Ichas F, Jouaville LS, Mazat JP. 1997. Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell 89:1145-1153.
158. Imberti R, Nieminen AL, Herman B, Lemasters JJ. 1992. Synergism of cyclosporin A and phospholipase inhibitors in protection against lethal injury to rat hepatocytes from oxidant chemicals. Res Commun Chem Path 78:27-38.
159. 2+-dependent collapse of mitochondrial membrane potential and ultrastructural alterations of mitochondria. FEBS Lett 392:143-147.
160. Jemmerson R, Dubinsky JM, Brustovetsky N. 2005. Cytochrome c release from CNS mitochondria and potential for clinical intervention in apoptosis-mediated CNS diseases. Antioxid Redox Signal 7:1158-1172.
161. Johans M, Milanesi E, Franck M, Johans C, Liobikas J, et al. 2005. Modification of permeability transition pore arginine (s) by phenylglyoxal derivatives in isolated mitochondria and mammalian cells. Structure-function relationship of arginine ligands. J Biol Chem 280:12130-12136.
162. Jorda EG, Jimenez A, Verdaguer E, Canudas AM, Folch J, et al. 2005. Evidence in favour of a role for peripheral-type benzodiazepine receptor ligands in amplification of neuronal apoptosis. Apoptosis 10:91-104.
163. 2+ changes with metabolic state in isolated heart mitochondria. Biochemistry 29:4121-4128.
164. Karasawa Y, Araki H, Otomo S. 1992. Effects of ketanserin and mianserin on delayed neuronal death induced by cerebral ischemia in Mongolian gerbils. Psychopharmacology (Berl) 109:264-270.
165. Karlsson J, Fong KS, Hansson MJ, Elmer E, Csiszar K, et al. 2004. Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis. J Neurosurg 101:128-137.
166. Kass GE, Juedes MJ, Orrenius S. 1992. Cyclosporin A protects hepatocytes
167. Keep M, Elmer E, Fong KS, Csiszar K. 2001. Intrathecal cyclosporin prolongs survival of late-stage ALS mice. Brain Res 894:327-331.
168. Khaspekov L, Friberg H, Halestrap A, Viktorov I, Wieloch T. 1999. Cyclosporin A and its nonimmunosuppressive analog N-Me-Va l-4-cyclosporin A mitigate glucose/oxygen deprivation-induced damage to rat cultured hippocampal neurons. Eur J Neurosci 11:3194-3198.
169. Kim JS, He L, Lemasters JJ. 2003. Mitochondrial permeability transition: A common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 304:463-470.
170. Kimelberg HK, Feustel PJ, Jin Y, Paquette J, Boulos A, et al. 2000. Acute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion. Neuroreport 11:2675-2679.
171. Kinnally KW, Campo ML, Tedeschi H. 1989. Mitochondrial channel activity studied by patch-clamping mitoplasts. J Bioenerg Biomembr 21:497-506.
172. Kinnally KW, Zorov DB, Antonenko YN, Snyder SH, McEnery MW, et al. 1993. Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. Proc Natl Acad Sci USA 90:1374-1378.
173. Klivenyi P, Calingasan NY, Starkov A, Stavrovskaya IG, Kristal BS, et al. 2004. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase. Neurobiol Dis 15:610-617.
174. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, et al. 1999. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5:347-350.
175. Knoll G, Brdiczka D. 1983. Changes in freeze-fractured mitochondrial membranes correlated to their energetic state. Dynamic interactions of the boundary membranes. Biochim Biophys Acta 733:102-110.
176. Kobayashi T, Kuroda S, Tada M, Houkin K, Iwasaki Y, et al. 2003. Calcium-induced mitochondrial swelling and cytochrome c release in the brain: Its biochemical characteristics and implication in ischemic neuronal injury. Brain Res 960:62-70.
177. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, et al. 2004. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427:461-465.
178. 2+ is dependent on mitochondrial-generated reactive oxygen species. FEBS Lett 378:150-152.
179. Kowaltowski AJ, Castilho RF, Vercesi AE. 2001. Mitochondrial permeability transition and oxidative stress. FEBS Lett 495:12-15.
180. Krauskopf A, Eriksson O, Craigen WJ, Forte MA, Bernardi P. 2006. Properties of the permeability transition in VDAC1 (-/-) mitochondria. Biochim Biophys Acta 1757:590-595.
181. Kristal BS, Dubinsky JM. 1997. Mitochondrial permeability transition in the central nervous system: Induction by calcium cycling-dependent and -independent pathways. J Neurochem 69:524-538.
182. Kristian T. 2004. Metabolic stages, mitochondria, and calcium in hypoxic/ischemic brain damage. Cell Calcium 36:221-233.
183. Kristian T, Bernardi P, Siesjo BK. 2001. Acidosis promotes the permeability transition in energized mitochondria: Implications for reperfusion injury. J Neurotrauma 18:1059-1074.
184. Kristian T, Gertsch J, Bates TE, Siesjo BK. 2000. Characteristics of the calcium-triggered mitochondrial permeability transition in nonsynaptic brain mitochondria: Effect of cyclosporin A and ubiquinone O. J Neurochem 74:1999-2009.
185. Kristian T, Weatherby TM, Bates TE, Fiskum G. 2002. Heterogeneity of the calcium-induced permeability transition in isolated nonsynaptic brain mitochondria. J Neurochem 83:1297-1308.
186. Kuroda S, Nakai A, Kristian T, Siesjo BK. 1997. The calmodulin antagonist trifluoperazine in transient focal brain ischemia in rats. Antiischemic effect and therapeutic window. Stroke 28:2539-2544.
187. Kushnareva YE, Sokolove PM. 2000. Prooxidants open both the mitochondrial permeability transition pore and a lowconductance channel in the inner mitochondrial membrane. Arch Biochem Biophys 376:377-388.
188. LaFrance R, Brustovetsky N, Sherburne C, Delong D, Dubinsky JM. 2005. Age-related changes in regional brain mitochondria from Fischer 344 rats. Aging Cell 4:139-145.
189. Lapidus RG, Sokolove PM. 1994. The mitochondrial permeability transition. Interactions of spermine, ADP, and inorganic phosphate. J Biol Chem 269:18931-18936.
190. Lardy HA, Pressman BC. 1956. Effect of surface active agents on the latent ATPase of mitochondria. Biochim Biophys Acta 21:458-466.
191. Le-Quoc K, Le-Quoc D. 1985. Crucial role of sulfhydryl groups in the mitochondrial inner membrane structure. J Biol Chem 260:7422-7428.
192. Leder O, Doring HJ, Reindell A, Fleckenstein A. 1969. Protective effect of organic Ca antagonists (iproveratril, D 600, prenylamine) against isoproterenol-induced myocardial necrosis. Pflugers Arch 312:R9-10.
193. Lehninger AL. 1949. Esterification of inorganic phosphate coupled to electron transport between dihydrodiphosdphopyridine nucleotide and oxygen. J Biol Chem 178:625-644.
194. Lehninger AL. 1962. Water uptake and extrusion by mitochondria in relation to oxidative phosphorylation. Physiol Rev 42:467-517.
195. Lehninger AL, Remmert LF. 1959. An endogenous uncoupling and swelling agent in liver mitochondria and its enzymic formation. J Biol Chem 234:2459-2464.
196. Lehninger AL, Carafoli E, Rossi CS. 1967. Energy-linked ion movements in mitochondrial systems. Adv Enzymol Relat Areas Mol Biol 29:259-320.
197. Leventhal L, Sortwell CE, Hanbury R, Collier TJ, Kordower JH, et al. 2000. Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity. J Comp Neurol 425:471-478.
198. Lin DT, Lechleiter JD. 2002. Mitochondrial targeted cyclophilin D protects cells from cell death by peptidyl prolyl isomerization. J Biol Chem 277:31134-31141.
199. 2+-induced membrane permeability transition in brain mitochondria. J Neurochem 79:1237-1245.
200. 2+ and respiratory chain complex II inhibition. J Neurochem 90:1025-1035.
201. Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, et al. 2004a. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 16:819-830.
202. Majewski N, Nogueira V, Robey RB, Hay N. 2004b. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol Cell Biol 24:730-740.
203. Mannella CA. 1998. Conformational changes in the mitochondrial channel protein, VDAC, and their functional implications. J Struct Biol 121:207-218.
204. Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, et al. 1998. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res Bull 46:281-309.
205. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, et al. 1998a. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281:2027-2031.
206. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, et al. 1998b. The permeability transition pore complex: A target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med 187:1261-1271.
207. Matsumoto S, Friberg H, Ferrand-Drake M, Wieloch T. 1999. Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 19:736-741.
208. Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, et al. 1998. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J Neurosci 18:156-163.
209. Mattiasson G, Friberg H, Hansson M, Elmer E, Wieloch T. 2003. Flow cytometric analysis of mitochondria from CA1 and CA3 regions of rat hippocampus reveals differences in permeability transition pore activation. J Neurochem 87:532-544.
210. McEnery MW. 1992. The mitochondrial benzodiazepine receptor: Evidence for association with the voltage-dependent anion channel (VDAC). J Bioenerg Biomembr 24:63-69.
211. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH. 1992. Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci USA 89:3170-3174.
212. 2+-dependent pore. Eur J Biochem 194:671-679.
213. McStay GP, Clarke SJ, Halestrap AP. 2002. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem J 367:541-548.
214. Merenda A, Bullock R. 2006. Clinical treatments for mitochondrial dysfunctions after brain injury. Curr Opin Crit Care 12:90-96.
215. Miller K, Sharer K, Suhan J, Koretsky AP. 1997. Expression of functional mitochondrial creatine kinase in liver of transgenic mice. Am J Physiol 272:C1193-C1202.
216. Milon L, Meyer P, Chiadmi M, Munier A, Johansson M, et al. 2000. The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinase. J Biol Chem 275:14264-14272.
217. Minamikawa T, Williams DA, Bowser DN, Nagley P. 1999. Mitochondrial permeability transition and swelling can occur reversibly without inducing cell death in intact human cells. Exp Cell Res 246:26-37.
218. Moreira PI, Custodio JB, Oliveira CR, Santos MS. 2004. Hydroxytamoxifen protects against oxidative stress in brain mitochondria. Biochem Pharmacol 68:195-204.
219. Moreira PI, Custodio JB, Oliveira CR, Santos MS. 2005. Brain mitochondrial injury induced by oxidative stress-related events is prevented by tamoxifen. Neuropharmacology 48:435-447.
220. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, et al. 2005. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434:652-658.
221. Nakata N, Kato H, Kogure K. 1992. Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil. Brain Res 590:48-52.
222. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, et al. 1998. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 95:14681-14686.
223. Nedergaard M, Ransom B, Goldman SA. 2003. New roles for astrocytes: Redefining the functional architecture of the brain. Trends Neurosci 26:523-530.
224. Newmeyer DD, Ferguson-Miller S. 2003. Mitochondria: Releasing power for life and unleashing the machineries of death. Cell 112:481-490.
225. Nicholls DG, Budd SL. 1998. Mitochondria and neuronal glutamate excitotoxicity. Biochim Biophys Acta 1366:97-112.
226. Nicholls DG, Chalmers S. 2004. The integration of mitochondrial calcium transport and storage. J Bioenerg Biomembr 36:277-281.
227. Nicholls DG, Scott ID. 1980. The regulation of brain mitochondrial calcium ion transport. The role of ATP in the discrimination between kinetic and membrane potentialdependent calcium ion efflux mechanisms. Biochem J 186:833-839.
228. Nicholls DG, Ward MW. 2000. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: Mortality and millivolts. Trends Neurosci 23:166-174.
229. Nicolli A, Petronilli V, Bernardi P. 1993. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by matrix pH. Evidence that the pore open-closed probability is regulated by reversible histidine protonation. Biochemistry 32:4461-4465.
230. Nieminen AL, Petrie TG, Lemasters JJ, Selman WR. 1996. Cyclosporin A delays mitochondrial depolarization induced by N-methyl-D-aspartate in cortical neurons: Evidence of the mitochondrial permeability transition. Neuroscience 75:993-997.
231. Nieminen AL, Saylor AK, Tesfai SA, Herman B, Lemasters JJ. 1995. Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide. Biochem J 307(Pt 1):99-106.
232. Norenberg MD, Rao KV, Jayakumar AR. 2005. Mechanisms of ammonia-induced astrocyte swelling. Metab Brain Dis 20:303-318.
233. Novgorodov SA, Gudz TI, Brierley GP, Pfeiffer DR. 1994. Magnesium ion modulates the sensitivity of the mitochondrial permeability transition pore to cyclosporin A and ADP. Arch Biochem Biophys 311:219-228.
234. Novgorodov SA, Gudz TI, Kushnareva YE, Zorov DB, Kudrjashov YB. 1990. Effect of ADP/ATP antiporter conformational state on the suppression of the nonspecific permeability of the inner mitochondrial membrane by cyclosporin A. FEBS Lett 277:123-126.
235. Novgorodov SA, Gudz TI, Milgrom YM, Brierley GP. 1992. The permeability transition in heart mitochondria is regulated synergistically by ADP and cyclosporin A. J Biol Chem 267:16274-16282.
236. O'Gorman E, Beutner G, Dolder M, Koretsky AP, Brdiczka D, et al. 1997. The role of creatine kinase in inhibition of mitochondrial permeability transition. FEBS Lett 414:253-257.
237. Okonkwo DO, Povlishock JT. 1999. An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J Cereb Blood Flow Metab 19:443-451.
238. Okonkwo DO, Melon DE, Pellicane AJ, Mutlu LK, Rubin DG, et al. 2003. Dose-response of cyclosporin A in attenuating traumatic axonal injury in rat. Neuroreport 14:463-466.
239. Ouyang YB, Tan Y, Comb M, Liu CL, Martone ME, et al. 1999. Survival- and death-promoting events after transient cerebral ischemia: Phosphorylation of Akt, release of cytochrome c, and activation of caspase-like proteases. J Cereb Blood Flow Metab 19:1126-1135.
240. Palmer GC, Harris EW, Ray R, Stagnitto ML, Schmiesing RJ. 1992. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro. Arch Int Pharmacodyn Ther 317:16-34.
241. Palmieri F. 2004. The mitochondrial transporter family (SLC25): Physiological and pathological implications. Pflugers Arch 447:689-709.
242. Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, et al. 2005. Rotenone model of Parkinson disease: Multiple brain mitochondria dysfunctions after short-term systemic rotenone intoxication. J Biol Chem 280:42026-42035.
243. Panov AV, Andreeva L, Greenamyre JT. 2004. Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: Comparison of rat liver and brain mitochondria. Arch Biochem Biophys 424:44-52.
244. Papadopoulos V, Amri H, Boujrad N, Cascio C, Culty M, et al. 1997. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62:21-28.
245. Parker MA, Bazan HE, Marcheselli V, Rodriguez de Turco EB, Bazan NG. 2002. Platelet-activating factor induces permeability transition and cytochrome c release in isolated brain mitochondria. J Neurosci Res 69:39-50.
246. Paschen SA, Waizenegger T, Stan T, Preuss M, Cyrklaff M, et al. 2003. Evolutionary conservation of biogenesis of β-barrel membrane proteins. Nature 426:862-866.
247. Pastorino JG, Hoek JB. 2003. Hexokinase II: The integration of energy metabolism and control of apoptosis. Curr Med Chem 10:1535-1551.
248. Pastorino JG, Chen ST, Tafani M, Snyder JW, Farber JL. 1998. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem 273:7770-7775.
249. Pastorino JG, Hoek JB, Shulga N. 2005. Activation of glycogen synthase kinase 3β disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res 65:10545-10554.
250. Pastorino JG, Shulga N, Hoek JB. 2002. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 277:7610-7618.
251. Pastorino JG, Tafani M, Rothman RJ, Marcineviciute A, Hoek JB, et al. 1999. Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore. J Biol Chem 274:31734-31739.
252. Penzo D, Tagliapietra C, Colonna R, Petronilli V, Bernardi P. 2002. Effects of fatty acids on mitochondria: Implications for cell death. Biochim Biophys Acta 1555:160-165.
253. 2+. J Biol Chem 268:1011-1016.
254. Petronilli V, Cola C, Massari S, Colonna R, Bernardi P. 1993b. Physiological effectors modify voltage sensing by the cyclosporin A-sensitive permeability transition pore of mitochondria. J Biol Chem 268:21939-21945.
255. Petronilli V, Costantini P, Scorrano L, Colonna R, Passamonti S, et al. 1994a. The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J Biol Chem 269:16638-16642.
256. Petronilli V, Nicolli A, Costantini P, Colonna R, Bernardi P. 1994b. Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim Biophys Acta 1187:255-259.
257. Petronilli V, Miotto G, Canton M, Brini M, Colonna R, et al. 1999. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 76:725-734.
258. Petronilli V, Szabo I, Zoratti M. 1989. The inner mitochondrial membrane contains ion-conducting channels similar to those found in bacteria. FEBS Lett 259:137-143.
259. Pfanner N, Wiedemann N, Meisinger C, Lithgow T. 2004. Assembling the mitochondrial outer membrane. Nat Struct Mol Biol 11:1044-1048.
260. 2+ plus N-ethylmaleimide on mitochondrial function. J Biol Chem 254:11485-11494.
261. Polster BM, Fiskum G. 2004. Mitochondrial mechanisms of neural cell apoptosis. J Neurochem 90:1281-1289.
262. Potter VR. 1947. The assay of animal tissues for respiratory enzymes. VI. Further studies on oxidative phosphorylation. J Biol Chem 169:17-37.
263. Puka-Sundvall M, Gilland E, Hagberg H. 2001. Cerebral hypoxia-ischemia in immature rats: Involvement of mitochondrial permeability transition? Dev Neurosci 23:192-197.
264. Raaflaub J. 1953. Swelling of isolated mitochondria of the liver and their susceptibility to physicochemical influences. Helv Physiol Pharmacol Acta 11:142-156.
265. Rama Rao KV, Jayakumar AR, Norenberg DM. 2003. Ammonia neurotoxicity: Role of the mitochondrial permeability transition. Metab Brain Dis 18:113-127.
266. Rama Rao KV, Jayakumar AR, Norenberg MD. 2005. Role of oxidative stress in the ammonia-induced mitochondrial permeability transition in cultured astrocytes. Neurochem Int 47:31-38.
267. Reichert SA, Kim-Han JS, Dugan LL. 2001. The mitochondrial permeability transition pore and nitric oxide synthase mediate early mitochondrial depolarization in astrocytes during oxygen-glucose deprivation. J Neurosci 21:6608-6616.
268. Robb SJ, Robb-Gaspers LD, Scaduto RC, Jr., Thomas AP, Connor JR. 1999. Influence of calcium and iron on cell death and mitochondrial function in oxidatively stressed astrocytes. J Neurosci Res 55:674-686.
269. Robertson CL, Bucci CJ, Fiskum G. 2004. Mitochondrial response to calcium in the developing brain. Brain Res Dev Brain Res 151:141-148.
270. 2+ uptake and retention. Biochim Biophys Acta 1016:87-98.
271. 2+ release: An intimate connection. Trends Biochem Sci 25:215-221.
272. Rytter A, Cardoso CM, Johansson P, Cronberg T, Hansson MJ, et al. 2005. The temperature dependence and involvement of mitochondria permeability transition and caspase activation in damage to organotypic hippocampal slices following in vitro ischemia. J Neurochem 95:1108-1117.
273. 2+ transport. Biochim Biophys Acta 1661:113-124.
274. Sampson MJ, Decker WK, Beaudet AL, Ruitenbeek W, Armstrong D, et al. 2001. Immotile sperm and infertility in mice lacking mitochondrial voltage-dependent anion channel type 3. J Biol Chem 276:39206-39212.
275. Sanchez Mejia RO, Ona VO, Li M, Friedlander RM. 2001. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48:1393-1399; discussion 1399-1401.
276. Santos JB, Schauwecker PE. 2003. Protection provided by cyclosporin A against excitotoxic neuronal death is genotype dependent. Epilepsia 44:995-1002.
277. Schanne FA, Kane AB, Young EE, Farber JL. 1979. Calcium dependence of toxic cell death: A final common pathway. Science 206:700-702.
278. Schinder AF, Olson EC, Spitzer NC, Montal M. 1996. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 16:6125-6133.
279. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, et al. 2005. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci USA 102:12005-12010.
280. Schmidt-Kastner R, Truettner J, Zhao W, Belayev L, Krieger C, et al. 2000. Differential changes of bax, caspase-3, and p21 mRNA expression after transient focal brain ischemia in the rat. Brain Res Mol Brain Res 79:88-101.
281. Schon EA, Manfredi G. 2003. Neuronal degeneration and mitochondrial dysfunction. J Clin Invest 111:303-312.
282. Schonfeld P, Bohnensack R. 1997. Fatty acid-promoted mitochondrial permeability transition by membrane depolarization and binding to the ADP/ATP carrier. FEBS Lett 420:167-170.
283. Schubert A, Grimm S. 2004. Cyclophilin D, a component of the permeability transition-pore, is an apoptosis repressor. Cancer Res 64:85-93.
284. Schultheiss HP, Klingenberg M. 1984. Immunochemical characterization of the adenine nucleotide translocator. Organ specificity and conformation specificity. Eur J Biochem 143:599-605.
285. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, et al. 2002. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2:55-67.
286. Scorrano L, Nicolli A, Basso E, Petronilli V, Bernardi P. 1997. Two modes of activation of the permeability transition pore: The role of mitochondrial cyclophilin. Mol Cell Biochem 174:181-184.
287. Scorrano L, Penzo D, Petronilli V, Pagano F, Bernardi P. 2001. Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-A aopototic signaling. J Biol Chem 276:12035-12040.
288. Shiga Y, Onodera H, Matsuo Y, Kogure K. 1992. Cyclosporin A protects against ischemia-reperfusion injury in the brain. Brain Res 595:145-148.
289. Siesjo BK. 1981. Cell damage in the brain: A speculative synthesis. J Cereb Blood Flow Metab 1:155-185.
290. Sims NR, Anderson MF. 2002. Mitochondrial contributions to tissue damage in stroke. Neurochem Int 40:511-526.
291. Singleton RH, Stone JR, Okonkwo DO, Pellicane AJ, Povlishock JT. 2001. The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury. J Neurotrauma 18:607-614.
292. Slater EC, Cleland KW. 1953. The effect of calcium on the respiratory and phosphorylative activities of heart-muscle sarcosomes. Biochem J 55:566-590.
293. Smith DH, Chen XH, Pierce JE, Wolf JA, Trojanowski JQ, et al. 1997. Progressive atrophy and neuron death for one year following brain trauma in the rat. J Neurotrauma 14:715-727.
294. Snyder JW, Pastorino JG, Attie AM, Farber JL. 1992. Protection by cyclosporin A of cultured hepatocytes from the toxic consequences of the loss of mitochondrial energization produced by 1-methyl-4-phenylpyridinium. Biochem Pharmacol 44:833-835.
295. Solenski NJ, Kostecki VK, Dovey S, Periasamy A. 2003. Nitricoxide-induced depolarization of neuronal mitochondria: Implications for neuronal cell death. Mol Cell Neurosci 24:1151-1169.
296. 2+-induced mitochondrial oxidative stress and PC12 cell death. Signal 7:1110-1116.
297. 2+-induced oxidative stress in brain mitochondria treated with the respiratory chain inhibitor rotenone. FEBS Lett 543:179-183.
298. Speer O, Back N, Buerklen T, Brdiczka D, Koretsky A, et al. 2005. Octameric mitochondrial creatine kinase induces and stabilizes contact sites between the inner and outer membrane. Biochem J 385:445-450.
299. Spierings D, McStay G, Saleh M, Bender C, Chipuk J, et al. 2005. Connected to death: The (unexpurgated) mitochondrial pathway of apoptosis. Science 310:66-67.
300. Starkov AA, Chinopoulos C, Fiskum G. 2004. Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell Calcium 36:257-264.
301. 2+-dependent uncoupling and activation of external pathway of NADH oxidation are coupled to cyclosporin A-sensitive mitochondrial permeability transition. Biochem Mol Biol Int 32:1147-1155.
302. Stavrovskaya IG, Narayanan MV, Zhang W, Krasnikov BF, Heemskerk J, et al. 2004. Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology. J Exp Med 200:211-222.
303. Sullivan PG, Rabchevsky AG, Hicks RR, Gibson TR, Fletcher-Turner A, et al. 2000. Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 101:289-295.
304. Sullivan PG, Rabchevsky AG, Waldmeier PC, Springer JE. 2005. Mitochondrial permeability transition in CNS trauma: Cause or effect of neuronal cell death? J Neurosci Res 79:231-239.
305. Swanson RA, Ying W, Kauppinen TM. 2004. Astrocyte influences on ischemic neuronal death. Curr Mol Med 4:193-205.
306. Szabo I, Zoratti M. 1991. The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A. J Biol Chem 266:3376-3379.
307. Szabo I, Zoratti M. 1993. The mitochondrial permeability transition pore may comprise VDAC molecules. I. Binary structure and voltage dependence of the pore. FEBS Lett 330:201-205.
308. Szabo I, De Pinto V, Zoratti M. 1993. The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel. FEBS Lett 330:206-210.
309. Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, et al. 2004. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci USA 101:3071-3076.
310. 2+ exchange are reduced in Alzheimer's disease cybrids. Mitochondrion 5:109-119.
311. Thompson HJ, Lifshitz J, Marklund N, Grady MS, Graham DI, et al. 2005. Lateral fluid percussion brain injury: A 15-year review and evaluation. J Neurotrauma 22:42-75.
312. Uchino H, Elmer E, Uchino K, Li PA, He QP, et al. 1998. Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat. Brain Res 812:216-226.
313. Uchino H, Elmer E, Uchino K, Lindvall O, Siesjo BK. 1995. Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat. Acta Physiol Scand 155:469-471.
314. Uchino H, Minamikawa-Tachino R, Kristian T, Perkins G, Narazaki M, et al. 2002. Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition. Neurobiol Dis 10:219-233.
315. Van Lookeren Campagne M, Gill R. 1996. Ultrastructural morphological changes are not characteristic of apoptotic cell death following focal cerebral ischaemia in the rat. Neurosci Lett 21:111-114.
316. Veech RL, Lawson JW, Cornell NW, Krebs HA. 1979. Cytosolic phosphorylation potential. J Biol Chem 254:6538-6547.
317. Verrier F, Mignotte B, Jan G, Brenner C. 2003. Study of PTPC composition during apoptosis for identification of viral protein target. Ann N Y Acad Sci 1010:126-142.
318. Vyssokikh M, Zorova L, Zorov D, Heimlich G, Jurgensmeier J, et al. 2004. The intramitochondrial cytochrome c distribution varies correlated to the formation of a complex between VDAC and the adenine nucleotide translocase: This affects Bax-dependent cytochrome c release. Biochim Biophys Acta 1644:27-36.
319. Waldmeier PC, Zimmermann K, Qian T, Tintelnot-Blomley M, Lemasters JJ. 2003. Cyclophilin D as a drug target. Curr Med Chem 10:1485-1506.
320. Wang H, Yu SW, Koh DW, Lew J, Coombs C, et al. 2004. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J Neurosci 24:10963-10973.
321. Wei L, Ying DJ, Cui L, Langsdorf J, Yu SP. 2004. Necrosis, apoptosis, and hybrid death in the cortex and thalamus after barrel cortex ischemia in rats. Brain Res 1022:54-61.
322. White RJ, Reynolds IJ. 1996. Mitochondrial depolarization in glutamate-stimulated neurons: An early signal specific to excitotoxin exposure. J Neurosci 16:5688-5697.
323. Wieckowski MR, Wojtczak L. 1998. Fatty acid-induced uncoupling of oxidative phosphorylation is partly due to opening of the mitochondrial permeability transition pore. FEBS Lett 423:339-342.
324. Wieckowski MR, Brdiczka D, Wojtczak L. 2000. Long-chain fatty acids promote opening of the reconstituted mitochondrial permeability transition pore. FEBS Lett 484:61-64.
325. Wiedemann N, Frazier AE, Pfanner N. 2004. The protein import machinery of mitochondria. J Biol Chem 279:14473-14476.
326. Wieloch T. 1985. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 230:681-683.
327. Wojtczak L, Lehninger AL. 1961. Formation and disappearance of an endogenous uncoupling factor during swelling and contraction of mitochondria. Biochim Biophys Acta 51:442-456.
328. Wojtczak L, Wieckowski MR, Schonfeld P. 1998. Protonophoric activity of fatty acid analogs and derivatives in the inner mitochondrial membrane: A further argument for the fatty acid cycling model. Arch Biochem Biophys 357:76-84.
329. Woodfield K, Ruck A, Brdiczka D, Halestrap AP. 1998. Direct demonstration of a specific interaction between cyclophilin D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem J 336(Pt 2):287-290.
330. Xu X, Decker W, Sampson MJ, Craigen WJ, Colombini M. 1999. Mouse VDAC isoforms expressed in yeast: Channel properties and their roles in mitochondrial outer membrane permeability. J Membr Biol 170:89-102.
331. Yoshimoto T, Siesjo BK. 1999. Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res 839:283-291.
332. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769-15774.
333. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, et al. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96:13496-13500.
334. 3H]deoxyglucose. Neurochem Res 29:609-616.
335. Zamora M, Granell M, Mampel T, Vinas O. 2004. Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells. FEBS Lett 563:155-160.
336. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, et al. 1995a. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182:367-377.
337. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, et al. 1995b.
338. Zamzami N, Marchetti P, Castedo M, Hirsch T, Susin SA, et al. 1996. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 384:53-57.
339. Zborowski J, Wojtczak L. 1963. Induction of swelling of liver mitochondria by fatty acids of various chain lengths. Biochim Biophys Acta 70:596-598.
340. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, et al. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417:74-78.
341. Zivin JA, Kochhar A, Saitoh T. 1989. Phenothiazines reduce ischemic damage to the central nervous system. Brain Res 482:189-193.
342. Zizi M, Forte M, Blachly-Dyson E, Colombini M. 1994. NADH regulates the gating of VDAC, the mitochondrial outer membrane channel. J Biol Chem 269:1614-1616.
343. Zoratti M, Szabo I. 1995. The mitochondrial permeability transition. Biochim Biophys Acta 1241:139-176.
344. Zoratti M, Szabo I, De Marchi U. 2005. Mitochondrial permeability transitions: How many doors to the house? Biochim Biophys Acta 1706:40-52.